The European Union introduced the General Data Protection Regulation (GDPR) in 2018 and it forms part of current UK law. A long and complex piece of legislation, the GDPR governs the processing of ...

The growing use of genomic data in healthcare aims to balance predictive and diagnostic needs by supporting both disease prevention and clinical decision-making. Yet, the predictive potential of ...

Transcriptomics is the analysis of the transcriptome, the collection of all ribonucleic acid (RNA) that is present in a sample (a cell, tissue or organ) at a given time. RNA performs many functions ...

Advances in clinical genomics have been enabled by short-read sequencing (SRS) technologies, where the DNA is broken into pieces up to 300 base pairs long. While these technologies have many ...

This report by PHG Foundation for NHS England, The personalised medicine technology landscape presents an independent evidence synthesis to inform the NHS as it continues to develop its approaches and ...

Synthetic data is artificially generated data that reflects the properties and relationships found in real data. While synthetic data can play an important role in AIaMD development, its use in ...

In spite of the increasing drive towards digitisation and large investments in big data, the ‘digital revolution’ of personalised healthcare remains elusive. As Brexit begins to exert its influence on ...

The potential of polygenic scores to improve risk stratification has reignited enthusiasm around the use of genetic information to help predict and prevent common disease. A new report from the PHG ...

Cancer is a major health problem, and new approaches to predicting, preventing and treating this disease are being investigated all the time. It is also a complex disease, as a person’s environment, ...

Any changes in healthcare practice, including the introduction of tests, often requires consideration of their value. Clinical utility is a broad term that is used to denote this usefulness or value ...

Cancer care is changing. More personalised therapies are available, for a variety of cancers, which target tumours that harbour specific genetic mutations. To prescribe these therapies, a genetic test ...

In recent months, before attention shifted to the pressing issue of tackling the COVID-19 pandemic, artificial intelligence (AI) had been hitting the headlines in medical news. Most weeks saw the ...